ArticleCancer medicine2026
Age-Specific Trends in Carcinoma Incidence Among Adolescents and Young Adults in the United States, 1975-2021.
Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
introductionThe incidence of carcinomas among adolescents and young adults (AYAs; ages 15-39) is rising. However, most research treats AYAs as a single group, potentially obscuring important age- and sex-specific trends. This study examined long-term trends in carcinoma incidence among AYAs in the U.S., overall and by 5 year age groups.
methodsWe conducted a population-based, retrospective time-series analysis using data from eight U.S. cancer registries in the Surveillance, Epidemiology and End Results database. The study included 128,255 AYAs diagnosed with malignant carcinoma between 1975-2021. Average annual percent change (AAPC) in incidence rates was estimated using Joinpoint regression, stratified by age, sex, and carcinoma subtype.
resultsA total of 128,255 individuals, aged 15-39, who were diagnosed with carcinoma between 1975-2021; 77.5% of AYA carcinoma cases occurred in females. The overall incidence of carcinomas increased by 0.61% (CI: 0.43-0.80) per year in AYAs from 1975 to 2021, with similar increases observed in females (AAPC: 0.68%; 95% CI, 0.50-0.87) and males (AAPC: 0.71%; 95% CI, 0.45-0.97). When stratified by age group, overall carcinoma incidence increased in each 5-year group; the largest relative increase was in those aged 15-19 (AAPC: 1.66%; 95% CI, 0.71-2.62) and the smallest was in those aged 35-39 (AAPC: 0.48%; 95% CI, 0.22-0.74).
conclusionsCarcinoma incidence is increasing in the AYA population within each 5-year age group, including among adolescents, a group in which these cancers have historically been rare. These findings highlight the urgent need to investigate the causes of this increase to guide targeted prevention and early detection efforts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.